Send us Fan Mail

In this episode of the Life Science Success Podcast my guest is Jennifer Vavala, Founder & Principal at AlignPoint Partners. With more than 27 years in pharma, medical device, and diagnostics leading QA/QC in complex regulated organizations, she focuses on quality systems, inspection readiness, and operational delivery, and developed the Operational Stability Recalibration framework to help leaders rebalance escalating mandates with operating capacity before compliance or delivery risks surface.

00:00 Intro

00:30 Meet Jennifer Vavala

01:39 Microbiology Origins

04:13 Capacity Not Capability

08:43 Across Regulated Sectors

12:25 AlignPoint Partners Mission

13:15 Operational Stability Framework

18:02 Early Warning Signals

19:52 Inspection Readiness Reality

23:55 Executives And Regulators

32:37 Quality Leadership Future

36:15 Inspiration Concerns Excitement

39:39 Wrap Up And Where To Connect

40:19 Outro

Send us Fan Mail

In this episode of the Life Science Success Podcast my guest is Dean Erhardt, President and CEO at D2 Solutions. He brings more than 20 years of experience across pharmaceuticals and consumer products, with expertise in support program development, distribution, and specialty product management, and has worked with over 100 pharmaceutical, biotech, and medical device manufacturers as well as many small and midsized organizations on commercial operations, strategy, and national accounts.

00:00 Intro

00:34 Dean's career: HMO, Cardinal Health, Express Scripts

03:00 Founding D2 Solutions in 2008

04:00 Pricing strategy and middlemen taking 50–70% of revenue

08:00 What separates successful commercialization from failure

10:00 D2's three pillars: distribution, reimbursement, patient services

15:00 Pharmaceutical support programs for specialty medications

16:00 D2's digital patient engagement platform in action

21:00 Resource challenges for small and mid-sized pharma

22:00 Retail deserts and the rise of direct-to-consumer models

24:00 National accounts strategy and long-term payer relationships

26:00 When to engage D2 and cleaning up commercialization missteps

28:00 The prior authorization crisis

31:00 Leadership advice: one vision, said a million times

32:00 AI, remote surgery, and the future of care

34:00 Looming shortage of 3.9 million healthcare workers

36:00 Concerns: aging population, lost patients, NIH funding

37:00 Technology accelerating drug approvals

38:00 Outro

Send us Fan Mail

Jesse Mendelsohn and Michael Grosberg from Model N discuss why U.S. pricing complexity is spreading globally, the collapse of the PBM rebate model, what's really driving the pharmaceutical manufacturing boom, and why direct-to-consumer discount programs won't solve America's drug access problem.

00:00 Introduction to Life Science Success Podcast
00:34 Pressing Issues in Pharmaceutical Manufacturing
00:51 Introducing the Experts from Model N
03:08 Understanding International Reference Pricing
04:14 Impact of US Pricing on Global Drug Launches
09:26 Challenges with Pharmacy Benefit Managers
16:29 Domestic Manufacturing Boom in Pharmaceuticals
23:08 AI in Drug Discovery and Personalized Medicine
29:03 Access and Policy Discussion
30:01 Direct to Consumer Pricing
31:32 TrumpRx Overview
33:11 Compliance Challenges
38:30 Pharmaceutical Revenue Management
41:38 AI in Life Sciences
48:35 Future of Life Sciences
50:45 Concerns and Challenges
53:52 Excitement in Current Work
55:54 Conclusion and Final Thoughts